NMB innovators series. Professor Michael R. Kilbourn, PhD: An enduring legacy of mentorship, scientific curiosity and research excellence

NUCLEAR MEDICINE AND BIOLOGY · Published 2026-07-01 · DOI 10.1016/j.nucmedbio.2026.109660

Authors (1)

Peter J.H. Scott

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Scott, P. (2026). NMB innovators series. Professor Michael R. Kilbourn, PhD: An enduring legacy of mentorship, scientific curiosity and research excellence. NUCLEAR MEDICINE AND BIOLOGY. https://doi.org/10.1016/j.nucmedbio.2026.109660

Related articles

• Fully automated and GMP compliant synthesis of [195mPt]Cisplatin · NUCLEAR MEDICINE AND BIOLOGY · 2025 · Same journal
• Scandium-47 as a radionuclide precursor: Feasibility of production in a 47Ca/47Sc generator-like system · NUCLEAR MEDICINE AND BIOLOGY · 2025 · Same journal
• Locked and loaded – [13N]AMMO A fast and convenient, multidose synthesis of [13N]ammonia · NUCLEAR MEDICINE AND BIOLOGY · 2025 · Same journal
• Targeted Alpha Therapy Applications of Sodium-Phase Zirconium Phosphate with 225Ac · NUCLEAR MEDICINE AND BIOLOGY · 2025 · Same journal
• NMB Innovators Series Professor Yasuhisa Fujibayashi, PhD, DMedSci · NUCLEAR MEDICINE AND BIOLOGY · 2026 · Same journal
• Matched pair suitability of 89Zr and 177Lu-labeled L804-LLP2A theranostics for targeting VLA-4 in melanoma · NUCLEAR MEDICINE AND BIOLOGY · 2025 · Same journal
• Development of novel MnO2-based nanoparticles for PET/MRI-guided Alpha Therapy · NUCLEAR MEDICINE AND BIOLOGY · 2025 · Same journal
• NMB Innovators Series Professor Dae Yoon Chi, Ph.D.: Understanding of 18F-chemistry and its applications toward drug developments used in diagnosis and therapeutics · NUCLEAR MEDICINE AND BIOLOGY · 2026 · Same journal
• NMB innovators Series Professor Olof Solin: Bridging the gap between the targetry and clinical diagnostics · NUCLEAR MEDICINE AND BIOLOGY · 2026 · Same journal
• The influences of charge on the pharmacokinetic behaviour of copper-based radioimmunoconjugates · NUCLEAR MEDICINE AND BIOLOGY · 2025 · Same journal